Long-term outcomes for patients with univentricular hearts after Fontan surgery

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to systematically document and analyze long-term outcomes in patients who have undergone Fontan surgery for univentricular heart defects. It will investigate various factors influencing treatment outcomes, including lymphatic drainage disorders, immunological changes, and psychological and social development. The study will also assess liver and kidney health, cardiac function, and the impact of physical activity and early interventions on complications. Data will be collected through routine clinical assessments and standardized questionnaires over multiple time points.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* congenital heart defect of the univentricular type that has led to Fontan circulation

Exclusion Criteria:

* no exclusion criteria

Where it's running

• Universitätsklinikum
  Erlangen, Germany Recruiting

Study contacts

• Study coordinator: Isabelle Schöffl, PD
• Email: isabelle.schoeffl@uk-erlangen.de
• Phone: 09131 85 33750

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Fontan outcomes with low versus high lung blood flow in single‑ventricle hearts

  This project will test whether people with single‑ventricle congenital heart disease who have reduced versus increased pulmonary blood flow do better or worse after the Fontan operation.

  Recruiting National Cardiovascular Center Harapan Kita Hospital Indonesia · Jakarta, DKI Jakarta · NCT07535203

• Cardiac imaging for patients with Fontan circulation

  This study is testing if special heart scans can help find early heart problems in patients who have had Fontan surgery for univentricular heart conditions, so they can get treatment before things get worse.

  Recruiting Karolinska Institutet · Stockholm · NCT06735521

• Using lab-grown heart cells to treat congenital heart disease

  This study is testing if using heart cells made from patients' own skin can safely help people with congenital heart disease feel better.

  Recruiting Phase 1 HeartWorks, Inc. · Rochester, Minnesota · NCT05647213

• Evaluation of treatment for univentricular heart defects

  This study is testing a new treatment approach for children with univentricular heart defects to see if it can improve their care and lower the risk of death.

  Recruiting University of Erlangen-Nürnberg Medical School · Erlangen · NCT05620030

• Registry to evaluate the safety of a new venous cannula for patients with heart failure

  This study is testing the safety of a new venous cannula for patients with heart failure who are using a special heart pump to see how well it works and if it has any risks.

  Recruiting Berlin Heart GmbH · Munich · NCT04782232

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.